Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Medstar Health Research Institute
- Study ID
- NCT07390591
- Status
- Recruiting
Conditions
- Neurogenic Bladder
- Neurogenic Lower Urinary Tract Dysfunction
- Spinal Cord Injuries
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is: 1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations. Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.
Key Dates
- Start date
- Jun 19, 2025
- Status verified
- Dec 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
Primary Outcome Measure
Advancing intravesical instillation for urinary health [ Time Frame: 12 months ]
Central Contacts
- Christopher Riegner, MPH202-892-5857
- Inger Ljungberg, MPH202-877-1694
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medstar National Rehabilitation Hospital | Washington D.C. | District of Columbia | 20010 | Inger Ljungberg, MPH |
Find similar trials in Washington D.C., DC
Related Studies
- Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling CathetersPHASE2 · Recruiting · Medstar Health Research Institute · Washington D.C., District of Columbia
- Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic BladderRecruiting · The University of Texas Health Science Center, Houston · Washington D.C., District of Columbia
- Intravesical LGG VS Saline Bladder Wash RCTPHASE2 · Recruiting · Medstar Health Research Institute · Washington D.C., District of Columbia
- Spinal Cord Injury Model Systems (SCIMS) - Education ModuleRecruiting · University of Miami · Washington D.C., District of Columbia